keyword
https://read.qxmd.com/read/38490859/a-systematic-review-of-synchronous-telepharmacy-service-models-for-adult-outpatients-with-cancer
#21
REVIEW
Marissa Ryan, Tara Poke, Elizabeth C Ward, Christine Carrington, Centaine L Snoswell
BACKGROUND: Telephone and videoconsults are known synchronous telepharmacy modalities being used to respond to the demand for outpatient pharmacy services. However, little is known about the evidence for cancer telepharmacy service models. OBJECTIVES: To review existing evidence regarding synchronous telepharmacy service models for adult outpatients with cancer, with a secondary focus on outcomes, enablers, and barriers. METHODS: A PROSPERO registered systematic review was conducted using PubMed, CINAHL, and EMBASE in March 2023...
March 2, 2024: Research in Social & Administrative Pharmacy: RSAP
https://read.qxmd.com/read/38488695/evaluating-the-utility-of-procalcitonin-and-a-clinical-decision-support-tool-to-determine-duration-of-antimicrobial-therapy-for-respiratory-tract-infections
#22
JOURNAL ARTICLE
Rustin Pevehouse, Punit J Shah, Nitha Chou, Priya Oolut, Suneesh Nair, Raziuddin Ahmed
DISCLAIMER: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. PURPOSE: Procalcitonin (PCT) levels may play a role in decreasing the duration of antimicrobial therapy in institutions that have long durations of therapy for management of community-acquired pneumonia...
March 15, 2024: American Journal of Health-system Pharmacy: AJHP
https://read.qxmd.com/read/38477532/medical-cannabis-use-in-oncology-and-associated-outcomes-a-scoping-review
#23
REVIEW
Ana Carolina Valente, Luis Phillipe Nagem Lopes, Maria Eline Matheus
BACKGROUND: Natural and synthetic cannabinoids are being used worldwide to treat various symptoms in cancer patients. This study aims to map the therapeutic benefits and adverse effects associated with the use of cannabis-based drugs in these outcomes. METHODS: Following Joanna Briggs Institute guidelines a scoping review was conducted. The study protocol was available in the Open Science Framework public repository. An extensive search strategy involving databases like Cochrane Library, Embase, CINAHL, Medline/PubMed, Lilacs, Google Scholar, and Open Gray for gray literature analysis was executed by a skilled librarian...
March 13, 2024: Journal of Oncology Pharmacy Practice
https://read.qxmd.com/read/38470172/characterizing-redundancy-in-pharmacy-residency-research-projects
#24
JOURNAL ARTICLE
Lauren S Yeager, Michael Behal, Alexander H Flannery, Dina Ali, Jordan Livingston, Blake Woodward, Aaron M Cook
DISCLAIMER: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. PURPOSE: Each year, roughly 5,000 residents conduct research on clinical and practice-based topics to meet the requirements of the ASHP residency standards related to research and project management...
March 12, 2024: American Journal of Health-system Pharmacy: AJHP
https://read.qxmd.com/read/38466965/evidence-based-use-of-bevacizumab-in-the-management-of-neovascular-age-related-macular-degeneration
#25
REVIEW
Rishi P Singh, Robert L Avery, Mark R Barakat, Judy E Kim, Szilárd Kiss
Indicated for colorectal cancer for decades, bevacizumab has been widely used off label to treat retinal diseases, and the benefits of its use, specifically in neovascular age-related macular degeneration, have been demonstrated in multiple clinical trials. The intravitreal delivery of bevacizumab requires it to be aseptically repackaged into individual syringes by compounding pharmacies for use in the eye. Although the repackaging process is permitted by the US Food and Drug Administration, the resultant product does not meet the specific standards of products approved for use as ophthalmic injectables nor is the parenteral innovator solution compliant with ophthalmic standards...
March 2024: Ophthalmic Surgery, Lasers & Imaging Retina
https://read.qxmd.com/read/38463172/the-quality-of-pharmacist-led-community-warfarin-management-across-2-provinces-in-canada-a-cross-sectional-observational-study
#26
JOURNAL ARTICLE
Laura Morrison, Jeff Nagge
BACKGROUND: Guidelines for anticoagulation management services recommend personnel be specially trained in warfarin management and suggest using tools such as decision-support software. To date, there have been no Canadian studies documenting the quality of warfarin management using a similar guideline recommended approach. METHODS: A cross-sectional, retrospective observational study was conducted to measure the quality of pharmacist-led warfarin management using point-of-care international normalized ratio (INR) testing and decision-support software in various ambulatory settings in Canada...
2024: Canadian Pharmacists Journal: CPJ
https://read.qxmd.com/read/38462441/medical-economic-effect-of-pharmaceutical-interventions-by-board-certified-pharmacists-in-palliative-pharmacy-for-patients-with-cancer-using-medical-narcotics-in-japan-a-multicenter-retrospective-study
#27
JOURNAL ARTICLE
Takehiro Kawashiri, Hideki Sugawara, Katsuya Makihara, Rintaro Ohno, Yoshihiro Miyamoto, Noriaki Hidaka, Mayako Uchida, Hisamitsu Takase
BACKGROUND: The Japanese Society for Pharmaceutical Palliative Care and Sciences specializes in pharmacology in the field of palliative medicine. More than 700 board-certified pharmacists in palliative pharmacy (BCPPP) are actively involved in palliative pharmacotherapy at various hospitals and pharmacies. The purpose of this study was to determine the economic effect of pharmaceutical interventions by BCPPPs. METHODS: This multicenter retrospective study included 27 medical centers and analyzed the medical economic effect of interventions by BCPPPs (17 pharmacists) and non-BCPPPs (24 pharmacists) on patients using medical narcotics for cancer pain in September 2021...
2024: Journal of Nippon Medical School
https://read.qxmd.com/read/38455672/effectiveness-of-clinical-pharmacist-interventions-in-optimizing-pharmacotherapy-for-somatic-comorbidities-in-serious-mental-illness-a-clinical-audit
#28
JOURNAL ARTICLE
Diamantis Klimentidis
BACKGROUND: Clinical pharmacists significantly improve pharmacotherapy outcomes. Patients with serious mental illness (SMI) represent a group particularly vulnerable to medication mismanagement, potentially benefiting from pharmaceutical care targeting medication appropriateness. OBJECTIVE: This study aimed to assess the prevalence of inappropriate medication for somatic comorbidities in SMI patients and to evaluate the impact of clinical pharmacist-led interventions...
March 2024: Explor Res Clin Soc Pharm
https://read.qxmd.com/read/38450360/association-of-gabapentinoids-with-opioid-related-overdose-in-the-inpatient-setting-a-single-center-retrospective-case-control-study
#29
JOURNAL ARTICLE
Shelby R Humpert, Kelly R Reveles, Kajal Bhakta, Sorina B Torrez, Kirk E Evoy
Objectives: Recent data suggest concomitant gabapentinoid use increases opioid-related overdose (ORO) risk; however, this association has not been well studied in the hospital setting. The primary objective of this study was to compare ORO risk, indicated by naloxone administration, in patients receiving opioids plus gabapentinoids versus opioids alone. Methods: In this retrospective case-control study of adults admitted to a large community hospital from 1/1/20 to 12/31/21, all cases (defined as patients who received naloxone more than 24 hours after admission) identified were matched 1:1 to randomly selected controls (defined as patients on opioids who did not receive naloxone)...
April 2024: Hospital Pharmacy
https://read.qxmd.com/read/38433868/phase-1-trial-of-same-day-cytology-to-guide-the-use-of-hipec
#30
JOURNAL ARTICLE
Paul H Sugarbaker, Tom Deng
BACKGROUND: Peritoneal metastases from gastrointestinal or gynecologic malignancy are a prominent part of the natural history of these diseases. Peritoneal metastases, if not effectively treated, will result in a decreased survival and cause an impaired quality of life. Hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment specifically designed to combat peritoneal metastases. A group of patients who, from a theoretical perspective, may benefit from HIPEC are those patients with a positive peritoneal cytology...
March 2024: International journal of surgery protocols
https://read.qxmd.com/read/38431771/enhancing-patient-adherence-to-newly-prescribed-medicine-for-chronic-diseases-a-comprehensive-review-and-cost-effective-approach-to-implementing-the-new-medicine-service-in-community-pharmacies-in-poland
#31
JOURNAL ARTICLE
Piotr Merks, Beata Chełstowska, Urszula Religioni, Agnieszka Neumann-Podczaska, Zbigniew Krasiński, Adam Kobayashi, Katarzyna Plagens-Rotman, Ewelina Drelih, Katarina Fehir-Sola, Łukasz Fijałkowski, Izabela Baj, Regis Vaillancourt, Katarzyna Wieczorowska-Tobis, Agnieszka Mastalerz-Migas, Mark Koziol, Jarosław Pinkas, Filip M Szymański, Dagmara Hering
New Medicine Service (NMS) components are an important element to improve patient compliance with medical recommendations. NMS provides support to patients prescribed new medicines, helping them to manage long-term conditions. The purpose of this service is to provide patients with advice, guidelines, and educational materials regarding the use of new medicines to increase patient compliance and therapy safety. The NMS has already been introduced in many European countries. This review aims to identify the benefits and potential barriers to implementing the NMS in community pharmacies and to suggest solutions that would increase its effectiveness...
March 3, 2024: Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
https://read.qxmd.com/read/38427331/a-primer-on-quality-measurement-and-reporting-in-pharmacy-benefit-plans
#32
JOURNAL ARTICLE
Stephen J Kogut
Pharmacy benefit plans in the United States are evaluated on quality measures and other requirements of the government and accrediting organizations. This primer describes the roles of key organizations involved in measuring and reporting quality in pharmacy benefit plans and explains the methods that pharmacy benefit plans use to promote quality of medication use.
March 1, 2024: Journal of Managed Care & Specialty Pharmacy
https://read.qxmd.com/read/38427164/glycemic-and-cost-outcomes-among-hispanic-latino-people-with-type-2-diabetes-in-the-usa-initiating-dulaglutide-versus-basal-insulin-a-real-world-study
#33
JOURNAL ARTICLE
Meredith Hoog, Juan M Maldonado, Ruth Wangia-Dixon, Rachel Halpern, Erin Buysman, Garrett W Gremel, Ahong Huang, Manige Konig
INTRODUCTION: Optimal glycemic management after diabetes onset remains a challenge in Hispanic/Latino adults with type 2 diabetes (T2D), often resulting in poor health outcomes and higher rates of diabetes-related complications. The aim of this study was to examine and compare demographic and clinical characteristics, glycemic outcomes, health care resource utilization (HCRU), and costs among injection-naïve Hispanic/Latino adults with T2D initiating dulaglutide or basal insulin...
March 1, 2024: Diabetes Therapy: Research, Treatment and Education of Diabetes and related Disorders
https://read.qxmd.com/read/38423929/harmonizing-the-definition-of-medication-reviews-for-their-collaborative-implementation-and-documentation-in-electronic-patient-records-a-delphi-consensus-study
#34
JOURNAL ARTICLE
Noora Lias, Tanja Lindholm, Anna-Riia Holmström, Marjo Uusitalo, Kirsi Kvarnström, Terhi Toivo, Harri Nurmi, Marja Airaksinen
BACKGROUND: Medication review practices have evolved internationally in a direction in which not only physicians but also other healthcare professionals conduct medication reviews according to agreed practices. Collaborative practices have increasingly highlighted the need for electronic joint platforms where information on medication regimens and their implementation can be documented, kept updated, and shared. OBJECTIVE: The aim of this study was to harmonize the definition of medication reviews and create a unified conceptual basis for their collaborative implementation and documentation in electronic patient records (definition appellation: collaborative medication review)...
February 8, 2024: Research in Social & Administrative Pharmacy: RSAP
https://read.qxmd.com/read/38423927/blockchain-technology-a-potential-tool-for-the-management-of-pharma-supply-chain
#35
REVIEW
Wasim Akram, Ramakant Joshi, Tanweer Haider, Pankaj Sharma, Vinay Jain, Navneet Garud, Nitin Singh
BACKGROUND: The pharma supply chain comprises various parties including distributors, manufacturers, raw material suppliers, regulators, pharmacies, hospitals, and patients. Due to the product's complexity and transaction flows, an efficient traceability system is needed in the pharma supply chain to identify the current and all previous product owners. Digitizing the track and trace process significantly improves regulatory oversight and guarantees product quality. A distributed platform for shared data that is immutable, trustworthy, accountable, and transparent in the pharmaceutical supply chain could be built using blockchain-based drug traceability...
February 23, 2024: Research in Social & Administrative Pharmacy: RSAP
https://read.qxmd.com/read/38392926/managing-dry-eye-disease-with-novel-medications-mechanism-study-validity-safety-efficacy-and-practical-application
#36
REVIEW
Jason C Wong, Aselle Barak
Dry eye disease (DED) is a common condition that affects mainly older individuals and women. It is characterized by reduced tear production and increased tear evaporation. Symptoms include burning, irritation, tearing, and blurry vision. This paper reviews key trials of various new DED treatments, including their mechanism of action, study outcomes, safety, and efficacy. The paper also includes a critical assessment of the trial's validity and potential pharmacy applications of these new treatments. The literature search was conducted through PubMed, the Cochrane Central Register of Controlled Trials, and Google Scholar...
January 23, 2024: Pharmacy (Basel, Switzerland)
https://read.qxmd.com/read/38384362/what-a-pain-in-the-%C3%A2-back-a-review-of-current-treatment-options-with-a-focus-on-naproxen-sodium
#37
REVIEW
Steven M Weisman, Giovanni Ciavarra, Grant Cooper
Non-specific low back pain (LBP) represents a challenging and prevalent condition that is one of the most common symptoms leading to primary care physician visits. While established guidelines recommend prioritizing non-pharmacological approaches as the primary course of action, pharmacological treatments are advised when non-pharmacological approaches are ineffective or based on patient preference. These guidelines recommend non-steroidal anti-inflammatory drugs (NSAIDs) or skeletal muscle relaxers (SMRs) as the first-line pharmacological options for acute or subacute LBP, while NSAIDs are the exclusive first-line pharmacological option for chronic LBP...
2024: Journal of Pharmacy & Pharmaceutical Sciences: a Publication of the Canadian Society for Pharmaceutical Sciences
https://read.qxmd.com/read/38373082/impact-of-a-pharmacy-technician-on-an-interprofessional-antithrombotic-stewardship-program-at-an-academic-medical-center
#38
JOURNAL ARTICLE
William M Hammonds, Emily Bowman, Amber N Chiplinski, Tessa A Keeting, Sarah M Pagenhardt, Patricia Valdez, Ashley F Street, Marco Caccamo, Daniel O'Neil, Julie E Peters, Stephanie L Stoffa
DISCLAIMER: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. PURPOSE: The need for monitoring and standardization of anticoagulation management has garnered the attention of national organizations, driving the implementation of antithrombotic stewardship programs (ASPs)...
February 19, 2024: American Journal of Health-system Pharmacy: AJHP
https://read.qxmd.com/read/38368583/disease-modifying-medications-in-patients-with-rheumatoid-arthritis-in-the-usa-trends-from-2016-to-2021
#39
JOURNAL ARTICLE
Samuel K Peasah, Elizabeth C S Swart, Yan Huang, Sandra L Kane-Gill, Amy L Seybert, Urvashi Patel, Chronis Manolis, Chester B Good
BACKGROUND: Disease-modifying anti-rheumatic drugs (DMARDs), since their introduction in 1990, have revolutionized the management of rheumatoid arthritis. Newer DMARDs have recently been approved, influencing treatment patterns and clinical guidelines. OBJECTIVE: To update the current prescribing patterns of DMARDs in the pharmacotherapy of rheumatoid arthritis (RA) to include the pandemic era. METHODS: This was a retrospective cross-sectional multi-year study...
February 18, 2024: Drugs—Real World Outcomes
https://read.qxmd.com/read/38367746/heartburn-relief-is-the-major-unmet-need-for-drug-development-in-gastroesophageal-reflux-disease-threshold-value-analysis
#40
JOURNAL ARTICLE
Eric D Shah, Michael A Curley, Amit Patel, Wai-Kit Lo, Walter W Chan
BACKGROUND AND AIMS: Heartburn symptoms contribute to healthcare-seeking among patients with gastroesophageal reflux disease (GERD). Despite clinical guidance, management is often dictated by insurance restrictions. Several potassium-competitive acid blockers (PCAB) are under development as a new class of therapy. We performed economic analyses to align GERD drug development with the needs of gastroenterologists, insurers and patients in a value-based environment. METHODS: A decision-analytic model was constructed to compare vonoprazan 20mg daily (an example of a potassium-competitive acid blocker[PCAB]), common over-the-counter or prescription proton pump inhibitor (PPI) regimens, and no treatment over a one-year time horizon...
February 15, 2024: Clinical Gastroenterology and Hepatology
keyword
keyword
882
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.